DrugPatentWatch Database Preview
Cediprof Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for CEDIPROF INC, and what generic alternatives to CEDIPROF INC drugs are available?
CEDIPROF INC has three approved drugs.
There is one US patent protecting CEDIPROF INC drugs.
There are eight patent family members on CEDIPROF INC drugs in seven countries.
Summary for Cediprof Inc
| International Patents: | 8 |
| US Patents: | 1 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Cediprof Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-012 | Dec 8, 2003 | AB1,AB2,AB3 | RX | No | No | Start Trial | Start Trial | ||||
| Cediprof Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 208737-002 | Feb 1, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-008 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | 6,399,101 | Start Trial | Start Trial | |||
| Cediprof Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 208737-001 | Feb 1, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Cediprof Inc | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | TABLET;ORAL | 209211-002 | Sep 19, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-006 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | 6,399,101 | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cediprof Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-006 | Mar 1, 2002 | 6,399,101 | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | 6,399,101 | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-003 | Mar 1, 2002 | 6,399,101 | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-005 | Mar 1, 2002 | 6,399,101 | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-011 | Mar 1, 2002 | 6,399,101 | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-010 | Mar 1, 2002 | 6,399,101 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Cediprof Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 0174448 | Start Trial |
| Australia | 5295301 | Start Trial |
| Brazil | 0109736 | Start Trial |
| Australia | 2001252953 | Start Trial |
| Canada | 2404369 | Start Trial |
| European Patent Office | 1267999 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
